Effect of endothelin-1 on canine airway blood flow

Scott A Barman, J. L. Ardell, A. E. Taylor

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effect of endothelin-1 (ET-1) on the blood flow contributions of the pulmonary and systemic circulations to the trachea and main bronchi were measured in anesthetized dogs by injecting 15-μm radiolabeled microspheres into the right and left heart, respectively. After the microsphere injections the animals were killed, and the tracheal cartilage, tracheal muscle mucosa, and main bronchi were excised and collected for radioactive counting. The results of this study showed that under normal conditions tracheal blood flow was primarily systemic (>95% of total tracheal blood flow) averaging 25-50 ml/min/100 g, whereas both the pulmonary (9-10 ml/min/100 g) and systemic circulations (19-20 ml/min/100 g) contributed substantially to main bronchi blood flow. Administration of ET-1 i.v. decreased systemic tracheal cartilage blood flow from 25.3 ± 3.8 to 14.5 ± 2.8 ml/min/100 g, systemic tracheal mucosal blood flow from 50.0 ± 7.0 to 25.0 ± 7.0 ml/min/100 g, and systemic main bronchi blood flow from 19.4 ± 4.6 to 11.6 ± 3.4 ml/min/100 g (p<0.05). These results indicate that ET-1 is a potent constrictor of the airway circulation and may contribute to airway ischemia seen in different airway disease states.

Original languageEnglish (US)
JournalJournal of Cardiovascular Pharmacology
Volume22
Issue numberSUPPL. 8
StatePublished - Dec 1 1993

Fingerprint

Endothelin-1
Canidae
Bronchi
Microspheres
Cartilage
Pulmonary Circulation
Trachea
Mucous Membrane
Ischemia
Dogs
Muscles
Lung
Injections

Keywords

  • Endothelin
  • Main bronchi blood flow
  • Pulmonary
  • Radioactive microspheres
  • Systemic
  • Tracheal blood flow

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Effect of endothelin-1 on canine airway blood flow. / Barman, Scott A; Ardell, J. L.; Taylor, A. E.

In: Journal of Cardiovascular Pharmacology, Vol. 22, No. SUPPL. 8, 01.12.1993.

Research output: Contribution to journalArticle

Barman, Scott A ; Ardell, J. L. ; Taylor, A. E. / Effect of endothelin-1 on canine airway blood flow. In: Journal of Cardiovascular Pharmacology. 1993 ; Vol. 22, No. SUPPL. 8.
@article{10a10d2f468e4b748ca176aa25f905df,
title = "Effect of endothelin-1 on canine airway blood flow",
abstract = "The effect of endothelin-1 (ET-1) on the blood flow contributions of the pulmonary and systemic circulations to the trachea and main bronchi were measured in anesthetized dogs by injecting 15-μm radiolabeled microspheres into the right and left heart, respectively. After the microsphere injections the animals were killed, and the tracheal cartilage, tracheal muscle mucosa, and main bronchi were excised and collected for radioactive counting. The results of this study showed that under normal conditions tracheal blood flow was primarily systemic (>95{\%} of total tracheal blood flow) averaging 25-50 ml/min/100 g, whereas both the pulmonary (9-10 ml/min/100 g) and systemic circulations (19-20 ml/min/100 g) contributed substantially to main bronchi blood flow. Administration of ET-1 i.v. decreased systemic tracheal cartilage blood flow from 25.3 ± 3.8 to 14.5 ± 2.8 ml/min/100 g, systemic tracheal mucosal blood flow from 50.0 ± 7.0 to 25.0 ± 7.0 ml/min/100 g, and systemic main bronchi blood flow from 19.4 ± 4.6 to 11.6 ± 3.4 ml/min/100 g (p<0.05). These results indicate that ET-1 is a potent constrictor of the airway circulation and may contribute to airway ischemia seen in different airway disease states.",
keywords = "Endothelin, Main bronchi blood flow, Pulmonary, Radioactive microspheres, Systemic, Tracheal blood flow",
author = "Barman, {Scott A} and Ardell, {J. L.} and Taylor, {A. E.}",
year = "1993",
month = "12",
day = "1",
language = "English (US)",
volume = "22",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 8",

}

TY - JOUR

T1 - Effect of endothelin-1 on canine airway blood flow

AU - Barman, Scott A

AU - Ardell, J. L.

AU - Taylor, A. E.

PY - 1993/12/1

Y1 - 1993/12/1

N2 - The effect of endothelin-1 (ET-1) on the blood flow contributions of the pulmonary and systemic circulations to the trachea and main bronchi were measured in anesthetized dogs by injecting 15-μm radiolabeled microspheres into the right and left heart, respectively. After the microsphere injections the animals were killed, and the tracheal cartilage, tracheal muscle mucosa, and main bronchi were excised and collected for radioactive counting. The results of this study showed that under normal conditions tracheal blood flow was primarily systemic (>95% of total tracheal blood flow) averaging 25-50 ml/min/100 g, whereas both the pulmonary (9-10 ml/min/100 g) and systemic circulations (19-20 ml/min/100 g) contributed substantially to main bronchi blood flow. Administration of ET-1 i.v. decreased systemic tracheal cartilage blood flow from 25.3 ± 3.8 to 14.5 ± 2.8 ml/min/100 g, systemic tracheal mucosal blood flow from 50.0 ± 7.0 to 25.0 ± 7.0 ml/min/100 g, and systemic main bronchi blood flow from 19.4 ± 4.6 to 11.6 ± 3.4 ml/min/100 g (p<0.05). These results indicate that ET-1 is a potent constrictor of the airway circulation and may contribute to airway ischemia seen in different airway disease states.

AB - The effect of endothelin-1 (ET-1) on the blood flow contributions of the pulmonary and systemic circulations to the trachea and main bronchi were measured in anesthetized dogs by injecting 15-μm radiolabeled microspheres into the right and left heart, respectively. After the microsphere injections the animals were killed, and the tracheal cartilage, tracheal muscle mucosa, and main bronchi were excised and collected for radioactive counting. The results of this study showed that under normal conditions tracheal blood flow was primarily systemic (>95% of total tracheal blood flow) averaging 25-50 ml/min/100 g, whereas both the pulmonary (9-10 ml/min/100 g) and systemic circulations (19-20 ml/min/100 g) contributed substantially to main bronchi blood flow. Administration of ET-1 i.v. decreased systemic tracheal cartilage blood flow from 25.3 ± 3.8 to 14.5 ± 2.8 ml/min/100 g, systemic tracheal mucosal blood flow from 50.0 ± 7.0 to 25.0 ± 7.0 ml/min/100 g, and systemic main bronchi blood flow from 19.4 ± 4.6 to 11.6 ± 3.4 ml/min/100 g (p<0.05). These results indicate that ET-1 is a potent constrictor of the airway circulation and may contribute to airway ischemia seen in different airway disease states.

KW - Endothelin

KW - Main bronchi blood flow

KW - Pulmonary

KW - Radioactive microspheres

KW - Systemic

KW - Tracheal blood flow

UR - http://www.scopus.com/inward/record.url?scp=0027751993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027751993&partnerID=8YFLogxK

M3 - Article

C2 - 7509964

AN - SCOPUS:0027751993

VL - 22

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - SUPPL. 8

ER -